日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy

病例报告:成功使用emapalumab治疗CAR-T细胞疗法后出现严重神经毒性和噬血细胞性淋巴组织细胞增生症样症状的成人B细胞急性淋巴细胞白血病

Manghisi, Beatrice; Cotilli, Giulia; Fedele, Marilena; Perfetti, Paola; Terruzzi, Elisabetta; Verga, Luisa; Borin, Lorenza Maria; Carrer, Andrea; Fumagalli, Monica; Ferrari, Maria Beatrice; Moretti, Alex; Rona, Roberto; Benini, Annalisa; Vergnano, Beatrice; Palumbo, Giovanni; Zincone, Alessandra; Maglia, Oscar; Scollo, Chiara; Steidl, Carolina; Iovino, Lorenzo; Balduzzi, Adriana; Piazza, Rocco; Gambacorti-Passerini, Carlo; Parma, Matteo; Aroldi, Andrea

Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients With Lymphoproliferative Disorders on BTKi

在接受 BTKI 治疗的淋巴增生性疾病患者中,Tixagevimab/Cilgavimab 的暴露前预防

Zamprogna, Giulia; Frustaci, Anna Maria; Travi, Giovanna; Borella, Chiara; Reda, Gianluigi; Motta, Marina; Deodato, Marina; Bossi, Elisa; Mattiello, Veronica; Ferrari, Maria Beatrice; Cotilli, Giulia; Gambacorti-Passerini, Carlo; Cairoli, Roberto; Puoti, Massimo; Tedeschi, Alessandra

Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists

序贯使用 Efgartigimod 和 Romiplostim 可恢复两名既往接受过血小板生成素受体激动剂治疗的难治性血小板减少症患者的血小板反应。

Carpenedo, Monica; Zappaterra, Arianna; Ferrari, Beatrice; Cotilli, Giulia